Literature DB >> 1651207

Covariate adjustment of treatment effects in clinical trials.

P L Canner1.   

Abstract

It has been previously shown that the magnitude of adjustment of a treatment effect Z value for a baseline covariate depends on both the degree of disparity of the covariate between the treatment groups and the degree of correlation between the covariate and the outcome variable. In this article, the magnitude of adjustment is further explored and tabulated for a variety of situations. Theoretically, the magnitude of adjustment may be great, for example, from Z = 3.0 unadjusted to 13.1 adjusted, or Z = 2.0 unadjusted to -1.6 adjusted. However, in more practically realistic situations the magnitude of adjustment will generally fall in the range of 1 to 2 standard error units, when the Z value for disparity of the covariate between the treatment groups is as great as +/- 3. If there is perfect comparability of treatment groups with respect to baseline covariate, there may still be a sizable difference between adjusted and unadjusted Z value for treatment effect, with adjusted almost always greater in absolute value than unadjusted Z value.

Mesh:

Year:  1991        PMID: 1651207     DOI: 10.1016/0197-2456(91)90016-f

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  8 in total

1.  Prognostic factors in clinical trials.

Authors:  S Dahlberg; P Y Liu
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Impact of baseline covariate imbalance on bias in treatment effect estimation in cluster randomized trials: Race as an example.

Authors:  Siyun Yang; Monique Anderson Starks; Adrian F Hernandez; Elizabeth L Turner; Robert M Califf; Christopher M O'Connor; Robert J Mentz; Kingshuk Roy Choudhury
Journal:  Contemp Clin Trials       Date:  2019-06-20       Impact factor: 2.226

3.  Effect of CBT on Depressive Symptoms in Methadone Maintenance Patients Undergoing Treatment for Hepatitis C.

Authors:  Susan E Ramsey; Patricia A Engler; Michael D Stein; Richard A Brown; Patricia Cioe; Christopher W Kahler; Kittichai Promrat; Jennifer Rose; Jennifer Anthony; David A Solomon
Journal:  J Addict Res Ther       Date:  2011-05-13

4.  Stakeholder benefit from depression disease management: differences by rurality?

Authors:  Stanley Xu; Kathryn Rost; Fran Dong; L Miriam Dickinson
Journal:  J Behav Health Serv Res       Date:  2010-01-06       Impact factor: 1.505

5.  Augmenting usual care SSRIs with cognitive behavioral therapy for insomnia to improve depression outcomes in youth: Design of a randomized controlled efficacy-effectiveness trial.

Authors:  Greg Clarke; Christina R Sheppler; Alison J Firemark; Andreea M Rawlings; John F Dickerson; Michael C Leo
Journal:  Contemp Clin Trials       Date:  2020-02-28       Impact factor: 2.226

6.  A transdiagnostic sleep and circadian treatment to improve severe mental illness outcomes in a community setting: study protocol for a randomized controlled trial.

Authors:  Allison G Harvey; Kerrie Hein; Lu Dong; Freddie L Smith; Michael Lisman; Stephanie Yu; Sophia Rabe-Hesketh; Daniel J Buysse
Journal:  Trials       Date:  2016-12-20       Impact factor: 2.279

7.  Can integrating the Memory Support Intervention into cognitive therapy improve depression outcome? Study protocol for a randomized controlled trial.

Authors:  Allison G Harvey; Lu Dong; Jason Y Lee; Nicole B Gumport; Steven D Hollon; Sophia Rabe-Hesketh; Kerrie Hein; Kirsten Haman; Mary E McNamara; Claire Weaver; Armando Martinez; Haruka Notsu; Garret Zieve; Courtney C Armstrong
Journal:  Trials       Date:  2017-11-14       Impact factor: 2.279

8.  Study protocol: developing and evaluating an interactive web platform to teach children hunting, shooting and firearms safety: a randomized controlled trial.

Authors:  David C Schwebel; D Leann Long; Marissa Gowey; Joan Severson; Yefei He; Katelyn Trullinger
Journal:  BMC Public Health       Date:  2021-02-06       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.